MARK D. OKUSA, M.D.
Osteopathic Medicine at Hospital Dr, Charlottesville, VA

License number
Virginia 0101035775
Category
Osteopathic Medicine
Type
Nephrology
Address
Address
W Hospital Dr FLOOR 5TH, Charlottesville, VA 22908
Phone
(434) 924-1894
(434) 924-5848 (Fax)
(434) 980-6140
(434) 972-4266 (Fax)
National Provider ID: 1679618763
LicenseFiles verified this license of Nov 7, 2017 at the National Plan and Provider Enumeration System.

Personal information

See more information about MARK D. OKUSA at radaris.com
Name
Address
Phone
Mark Okusa
2250 Cornwall Rd, Charlottesvle, VA 22901
(434) 979-4392
Mark D Okusa, age 70
2250 Cornwall Rd, Charlottesvle, VA 22901
(434) 979-4392
(434) 924-1156

Professional information

See more information about MARK D. OKUSA at trustoria.com
Mark Okusa Photo 1
Chief Division Of Nephrology At University Of Virginia

Chief Division Of Nephrology At University Of Virginia
Position:
John C. Buchanan Distinguished Professor of Medicine, Chief, Division of Nephrology at University of Virginia
Location:
Charlottesville, Virginia Area
Industry:
Hospital & Health Care
Work:
University of Virginia since 1991 - John C. Buchanan Distinguished Professor of Medicine, Chief, Division of Nephrology Yale University School of Medicine Jul 1990 - Jun 1991 - Instructor of Medicine Yale University School of Medicine Jul 1988 - Jun 1990 - Associate Research Scientist Yale University 1985 - 1988 - Nephrology Fellow
Education:
Virginia Commonwealth University School of Medicine 1978 - 1982
MD, Medicine The George Washington University 1972 - 1976
BS, Biology

Mark D Okusa Photo 2
Dr. Mark D Okusa - MD (Doctor of Medicine)

Dr. Mark D Okusa - MD (Doctor of Medicine)
Hospitals:
West Complex
1300 Jefferson Park Ave, Charlottesville 22903
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
West Complex
1300 Jefferson Park Ave, Charlottesville 22903
University of Virginia Hospital
1215 Lee St, Charlottesville 22908
Education:
Medical Schools
Virginia Commonwealth University School Of Medicine
Graduated: 1982

Mark D Okusa Photo 3
Mark D Okusa, Charlottesville VA

Mark D Okusa, Charlottesville VA
Specialties:
Nephrologist
Address:
500 Ray C Hunt Dr, Charlottesville, VA 22903
Education:
Medical College of Virginia - Doctor of Medicine*
Yale New Haven Psychiatric Hospital - Fellowship - Nephrology (Internal Medicine)*
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine*, American Board of Internal Medicine Sub-certificate in Nephrology (Internal Medicine)*

Mark Okusa Photo 4
Methods And Compositions For Treating Inflammatory Response

Methods And Compositions For Treating Inflammatory Response

US Patent:
6531457, Mar 11, 2003
Filed:
Apr 5, 2001
Appl. No.:
09/827083
Inventors:
Joel M. Linden - Charlottesville VA
Gail W. Sullivan - Charlottesville VA
Ian J. Sarembock - Charlottesville VA
Timothy MacDonald - Charlottesville VA
Mark Okusa - Charlottesville VA
Irving L. Kron - Charlottesville VA
W. Michael Scheld - Earlysville VA
Assignee:
University of Virginia - Charlottesville PA
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A61K 3170
US Classification:
514 46
Abstract:
Compounds and methods are provided to treat inflammatory conditions with certain A adenosine receptor antagonists.

Mark Okusa Photo 5
Agonists Of A2A Adenosine Receptors For Treatment Of Diabetic Nephropathy

Agonists Of A2A Adenosine Receptors For Treatment Of Diabetic Nephropathy

US Patent:
7396825, Jul 8, 2008
Filed:
May 3, 2005
Appl. No.:
11/121169
Inventors:
Mark D. Okusa - Charlottesville VA, US
Joel M. Linden - Charlottesville VA, US
Timothy L. Macdonald - Charlottesville VA, US
Alaa S. Awad - Charlottesville VA, US
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A01N 43/04, A61K 31/70, C07H 19/00, C07H 19/22
US Classification:
514 45, 514 43, 514 48
Abstract:
The present invention provides a therapeutic method for treating diabetic kidney disease, e. g. , diabetic nephropathy that includes the administration of an effective amount of an Aadenosine receptor agonist. Optionally, the method includes administration of a type IV PDE inhibitor.

Mark Okusa Photo 6
Pharmaceutical Compositions Having Aadenosine Receptor Agonist Activity

Pharmaceutical Compositions Having Aadenosine Receptor Agonist Activity

US Patent:
7226913, Jun 5, 2007
Filed:
Mar 3, 2003
Appl. No.:
10/379154
Inventors:
Joel M. Linden - Charlottesville VA, US
Gail W. Sullivan - Charlottesville VA, US
Ian J. Sarembock - Charlottesville VA, US
Timothy MacDonald - Charlottesville VA, US
Mark Okusa - Charlottesville VA, US
Irving L. Kron - Charlottesville VA, US
W. Michael Scheld - Earlysville VA, US
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A61K 31/70
US Classification:
514 46
Abstract:
The present invention provides compositions for oral administration of compounds having Aadenosine receptor agonist activity. These compositions are useful for treatment of inflammatory conditions.

Mark Okusa Photo 7
Lysophosphatidic Acid Receptor Agonists And Antagonists

Lysophosphatidic Acid Receptor Agonists And Antagonists

US Patent:
7169818, Jan 30, 2007
Filed:
Oct 3, 2001
Appl. No.:
10/398305
Inventors:
Kevin R. Lynch - Charlottesville VA, US
Timothy L. Macdonald - Charlottesville VA, US
Christopher E. Heise - New York NY, US
Webster L. Santos - Cambridge MA, US
Mark D. Okusa - Charlottesville VA, US
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A01N 33/08
US Classification:
514667, 554 66, 554 40, 554 41, 564353, 564503
Abstract:
The present invention is directed to compositions comprising lysophosphatidic acid analogs and methods of using such analogs as agonist or antagonists of LPA receptor activity. In addition the invention is directed to LPA receptor agonists that vary in the degree of selectivity at individual LPA receptors (i. e. LPA1, LPA2 and LPA3). More particularly the present invention is directed to LPA analogs wherein the glycerol is replaced with ethanolamine and a variety of substitutions have been linked at the second carbon atom.

Mark Okusa Photo 8
Methods And Compositions For Treating Inflammatory Response

Methods And Compositions For Treating Inflammatory Response

US Patent:
2007026, Nov 15, 2007
Filed:
Apr 24, 2007
Appl. No.:
11/739680
Inventors:
Joel Linden - Charlottesville VA, US
Gail Sullivan - Charlottesville VA, US
Ian Sarembock - Charlottesville VA, US
Timothy MacDonald - Charlottesville VA, US
Mark Okusa - Charlottesville VA, US
Irving Kron - Charlottesville VA, US
W. Scheld - Earlysville VA, US
International Classification:
C07H 19/06
US Classification:
536027300
Abstract:
Compositions for oral administration of compounds having Aadenosine receptor antagonist activity are provided. These compositions are useful for treatment of inflammatory conditions.

Mark Okusa Photo 9
Methods And Compositions For Treating Inflammatory Response

Methods And Compositions For Treating Inflammatory Response

US Patent:
6232297, May 15, 2001
Filed:
Jun 15, 1999
Appl. No.:
9/333387
Inventors:
Joel M. Linden - Charlottesville VA
Gail W. Sullivan - Charlottesville VA
Ian J. Sarembock - Charlottesville VA
Timothy MacDonald - Charlottesville VA
Mark Okusa - Charlottesville VA
Assignee:
University of Virginia Patent Foundation - Charlottesville VA
International Classification:
A61K 3170, C07H 1916, C07H 19167, C07H 19173
US Classification:
514 46
Abstract:
Compounds and methods are provided to treat inflammatory conditions with certain A. sub. 2A adenosine receptor antagonists.

Osteopathic Medicine licenses in Virginia










Other Doctors licenses in Virginia